COVID-19 vaccines for 5-to-11-year-olds are inching closer: Here’s what we know so far
Australian children aged five to 11 could begin receiving the Pfizer vaccine by the end of November, with the nation’s regulator currently reviewing the health and safety data.
Pfizer submitted a partial application to Australia’s Therapeutic Goods Administration (TGA) last week and will supply the remaining data over the next two weeks. The TGA will then review all the information and make a decision about whether to approve the vaccine for use in this age group.
Barring any issues, TGA head John Skerritt expects a decision will be made by the end of November. The Australian Technical Advisory Group on Immunisation (ATAGI), will then advise the government on timing of the rollout.
So what does the data say so far on safety and efficacy? And what are the benefits of vaccinating children aged five to 11?
